Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2047-2026

Rolls of label stock used with the Omnicell i.v.Station. 1. Part Number 258920028, LABEL, STERILE, IVSTATION SYRINGE (40MMX40MM). 2. Part Number 258900029, LABEL, STERILE, IVSTATION SYRINGE (20MMX40MM). Recall

Rolls of label stock used with the Omnicell i.v.Station. 1. Part Number 258920028, LABEL, STERILE, IVSTATION SYRINGE (40MMX40MM). 2. Part Number 258900029, LABEL, STERILE, IVSTATION SYRINGE (20MMX40MM). Model/Catalog Number: IVS-RBT-001. i.v.STATION is an automation device used for preparation and compounding of IV medications, which also applies labels to compounded preparations for identification and traceability.

FDA recall Class I

Ongoing

FDA lists this Class I recall for Rolls of label stock used with the Omnicell i.v.Station. 1. Part Number 258920028, LABEL, STERILE, IVSTATION SYRINGE (40MMX40MM). 2. Part Number 258900029, LABEL, STERILE, IVSTATION SYRINGE (20MMX40MM).. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2047-2026
Recall classification
Class I
Enforcement status
Ongoing
Initiation date
Mar 25, 2026
FDA report date
May 20, 2026
Quantity in commerce
220 units
Distribution
See key details
FDA cause
Process control

What is being recalled?

Rolls of label stock used with the Omnicell i.v.Station. 1. Part Number 258920028, LABEL, STERILE, IVSTATION SYRINGE (40MMX40MM). 2. Part Number 258900029, LABEL, STERILE, IVSTATION SYRINGE (20MMX40MM). Model/Catalog Number: IVS-RBT-001. i.v.STATION is an automation device used for preparation and compounding of IV medications, which also applies labels to compounded preparations for identification and traceability.

Affected model & UDI checker

Search the exact identifiers published for Z-2047-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
IVS-RBT-001Rolls of label stock used with the Omnicell i.v.Station. 1. Part Number 258920028, LABEL, STERILE, IVSTATION SYRINGE (40MMX40MM). 2. Part Number 258900029, LABEL, STERILE, IVSTATION SYRINGE (20MMX40MM).Check source noticeNot specified
FDA code information

1. Part Number 258920028, Lot Number: QN 200023473. 2. Part Number 258900029, Lot Number: QN 200023474.

View the original FDA recall notice

Why was this product recalled?

Potential for mislabeled syringe produced by the i.v.STATION device.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Omnicell, Inc. take?

Omnicell initially notified consignees on about 03/25/2026 via email and internal communication methods to IVCS technicians (Omnicell personnel operating within the hospitals). The communication provided instruction to cease use of new syringe label rolls, any affected units on hand should be segregated and clearly labeled "Do Not Use" until further notice, and to use the old syringe label rolls with the yellow backing. A formal notification was sent on about 04/13/2026. Consignees were instructed that onsite IV Compounding Service Resident Robotic Experts (IVCS RRE(s)) have segregated the impacted stock of the above-identified labels at each facility and have been instructed to return it to Omnicell. If any staff locate any labels with the affected part numbers/names listed in the Alert, please immediately segregate and do not use the label(s), and contact Omnicell Technical Support. Additionally, Omnicell requested that consignees continue to engage in vigilant pharmacist verification practices to verify the accuracy of labels, continue to use previously ordered non-sterile syringe labels, share this information with all those who need to be aware within each organization, and complete and return the Customer Acknowledgment form. Omnicell has taken the following immediate containment actions in relation to this Alert: (1) directed the segregation and discontinuation of use of impacted sterile label stock at each facility; (2) directed resuming use of previously ordered non-sterile syringe labels; and (3) quarantined impacted sterile label stock at Omnicell s manufacturing facility. All immediate containment activities have been completed. Impacted sterile label stock at each facility will be returned to Omnicell by IVCS RRE(s). Any additional corrective or preventative actions will be identified and implemented per Omnicell s standard processes, based on the results of our on-going engineering investigation.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology